DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Zhu CQ, da Cunha SantosG, Ding K et al.
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR. 21.
J Clin Oncol 2008;
26: 4268-4275
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.